0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sex Hormones API Market Research Report 2025
Published Date: 2025-12-23
|
Report Code: QYRE-Auto-4W17045
Home | Market Reports | Health| Reproductive Health
Global Sex Hormones API Market Research Report 2024
BUY CHAPTERS

Global Sex Hormones API Market Research Report 2025

Code: QYRE-Auto-4W17045
Report
2025-12-23
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sex Hormones API Market Size

The global market for Sex Hormones API was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 756 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Sex Hormones API Market

Sex Hormones API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sex Hormones API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Sex hormone APIs are chemical raw materials for sex hormone drugs, including estrogen, progesterone and male hormones, such as estradiol, testosterone, progesterone, etc.
In 2024, global sales of sex hormone APIs reached 662.6 tons, with an average selling price of US$763/kg and a production capacity of approximately 1,600 tons. The industry's gross profit margin was above 40%. Cost structure: direct materials accounted for approximately 60%, manufacturing costs approximately 28%, and labor costs approximately 12%. Industry chain: upstream consists of starting materials and intermediates (chemical reagents, solvents, catalysts), while downstream consists of pharmaceutical manufacturers and the medical/end-user market.
The sex hormone API sector is evolving under a dual logic of technological advancement and industrial consolidation. Process innovations — including alternative synthetic routes and biological/enzymatic approaches — are enabling upstream feedstocks to be converted into higher-value APIs, encouraging companies to pursue vertical integration from starting materials through intermediates to finished APIs. This technical progress is reshaping competitive dynamics: firms that secure critical starting materials and mature process technologies gain advantages in cost control, regulatory readiness, and supply security. Opportunities lie in the commercialization of new process routes, expansion of downstream high-end API portfolios, and growth of CDMO offerings catering to stricter quality and registration needs. Key constraints are structural: cyclical price pressure, environmental and compliance burdens, and the high bar for regulatory approvals and GMP audits in major markets. In sum, the winners will be those who combine proprietary process capability with disciplined capacity management and regulatory competence.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sex Hormones API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sex Hormones API.
The Sex Hormones API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sex Hormones API market comprehensively. Regional market sizes, concerning products by Type, by Application, by Hormone Type and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sex Hormones API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Hormone Type and by regions.

Scope of Sex Hormones API Market Report

Report Metric Details
Report Name Sex Hormones API Market
Accounted market size in year US$ 506 million
Forecasted market size in 2031 US$ 756 million
CAGR 5.8%
Base Year year
Forecasted years 2026 - 2031
Segment by Type
  • Estrogens
  • Progestins
  • Androgens
Segment by Hormone Type
  • Progesterone
  • Estradiol
  • Ethinylestradiol
  • Levonorgestrel
  • Megestrol
  • Testosterone
  • Other
Segment by Source
  • Natural Hormones
  • Synthetic Hormones
Segment by Application
  • Oral Preparations
  • Topical Preparations
  • Injections
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer CentreOne, EUROAPI, GlaxoSmithKline, TAPI, Axplora, Steroid SpA, Symbiotec Pharmalab, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, Zhejiang Xianju Xianle Pharmaceutical, Hunan Yuxin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sex Hormones API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sex Hormones API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Sex Hormones API Market growing?

Ans: The Sex Hormones API Market witnessing a CAGR of 5.8% during the forecast period 2026-2031.

What is the Sex Hormones API Market size in 2031?

Ans: The Sex Hormones API Market size in 2031 will be US$ 756 million.

Who are the main players in the Sex Hormones API Market report?

Ans: The main players in the Sex Hormones API Market are Pfizer CentreOne, EUROAPI, GlaxoSmithKline, TAPI, Axplora, Steroid SpA, Symbiotec Pharmalab, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, Zhejiang Xianju Xianle Pharmaceutical, Hunan Yuxin Pharmaceutical

What are the Application segmentation covered in the Sex Hormones API Market report?

Ans: The Applications covered in the Sex Hormones API Market report are Oral Preparations, Topical Preparations, Injections

What are the Type segmentation covered in the Sex Hormones API Market report?

Ans: The Types covered in the Sex Hormones API Market report are Progesterone, Estradiol, Ethinylestradiol, Levonorgestrel, Megestrol, Testosterone, Other

1 Sex Hormones API Market Overview
1.1 Product Definition
1.2 Sex Hormones API by Type
1.2.1 Global Sex Hormones API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Estrogens
1.2.3 Progestins
1.2.4 Androgens
1.3 Sex Hormones API by Hormone Type
1.3.1 Global Sex Hormones API Market Value Comparison by Hormone Type: 2024 VS 2031
1.3.2 Progesterone
1.3.3 Estradiol
1.3.4 Ethinylestradiol
1.3.5 Levonorgestrel
1.3.6 Megestrol
1.3.7 Testosterone
1.3.8 Other
1.4 Sex Hormones API by Source
1.4.1 Global Sex Hormones API Market Value Comparison by Source: 2024 VS 2031
1.4.2 Natural Hormones
1.4.3 Synthetic Hormones
1.5 Sex Hormones API by Application
1.5.1 Global Sex Hormones API Market Value by Application (2024 VS 2031)
1.5.2 Oral Preparations
1.5.3 Topical Preparations
1.5.4 Injections
1.6 Global Sex Hormones API Market Size Estimates and Forecasts
1.6.1 Global Sex Hormones API Revenue 2020-2031
1.6.2 Global Sex Hormones API Sales 2020-2031
1.6.3 Global Sex Hormones API Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Sex Hormones API Market Competition by Manufacturers
2.1 Global Sex Hormones API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sex Hormones API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sex Hormones API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sex Hormones API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sex Hormones API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sex Hormones API, Product Type & Application
2.7 Global Key Manufacturers of Sex Hormones API, Date of Enter into This Industry
2.8 Global Sex Hormones API Market Competitive Situation and Trends
2.8.1 Global Sex Hormones API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sex Hormones API Players Market Share by Revenue
2.8.3 Global Sex Hormones API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sex Hormones API Market Scenario by Region
3.1 Global Sex Hormones API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sex Hormones API Sales by Region: 2020-2031
3.2.1 Global Sex Hormones API Sales by Region: 2020-2025
3.2.2 Global Sex Hormones API Sales by Region: 2026-2031
3.3 Global Sex Hormones API Revenue by Region: 2020-2031
3.3.1 Global Sex Hormones API Revenue by Region: 2020-2025
3.3.2 Global Sex Hormones API Revenue by Region: 2026-2031
3.4 North America Sex Hormones API Market Facts & Figures by Country
3.4.1 North America Sex Hormones API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sex Hormones API Sales by Country (2020-2031)
3.4.3 North America Sex Hormones API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sex Hormones API Market Facts & Figures by Country
3.5.1 Europe Sex Hormones API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sex Hormones API Sales by Country (2020-2031)
3.5.3 Europe Sex Hormones API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sex Hormones API Market Facts & Figures by Region
3.6.1 Asia Pacific Sex Hormones API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sex Hormones API Sales by Region (2020-2031)
3.6.3 Asia Pacific Sex Hormones API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sex Hormones API Market Facts & Figures by Country
3.7.1 Latin America Sex Hormones API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sex Hormones API Sales by Country (2020-2031)
3.7.3 Latin America Sex Hormones API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sex Hormones API Market Facts & Figures by Country
3.8.1 Middle East and Africa Sex Hormones API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sex Hormones API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sex Hormones API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sex Hormones API Sales by Type (2020-2031)
4.1.1 Global Sex Hormones API Sales by Type (2020-2025)
4.1.2 Global Sex Hormones API Sales by Type (2026-2031)
4.1.3 Global Sex Hormones API Sales Market Share by Type (2020-2031)
4.2 Global Sex Hormones API Revenue by Type (2020-2031)
4.2.1 Global Sex Hormones API Revenue by Type (2020-2025)
4.2.2 Global Sex Hormones API Revenue by Type (2026-2031)
4.2.3 Global Sex Hormones API Revenue Market Share by Type (2020-2031)
4.3 Global Sex Hormones API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sex Hormones API Sales by Application (2020-2031)
5.1.1 Global Sex Hormones API Sales by Application (2020-2025)
5.1.2 Global Sex Hormones API Sales by Application (2026-2031)
5.1.3 Global Sex Hormones API Sales Market Share by Application (2020-2031)
5.2 Global Sex Hormones API Revenue by Application (2020-2031)
5.2.1 Global Sex Hormones API Revenue by Application (2020-2025)
5.2.2 Global Sex Hormones API Revenue by Application (2026-2031)
5.2.3 Global Sex Hormones API Revenue Market Share by Application (2020-2031)
5.3 Global Sex Hormones API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer CentreOne
6.1.1 Pfizer CentreOne Company Information
6.1.2 Pfizer CentreOne Description and Business Overview
6.1.3 Pfizer CentreOne Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer CentreOne Sex Hormones API Product Portfolio
6.1.5 Pfizer CentreOne Recent Developments/Updates
6.2 EUROAPI
6.2.1 EUROAPI Company Information
6.2.2 EUROAPI Description and Business Overview
6.2.3 EUROAPI Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 EUROAPI Sex Hormones API Product Portfolio
6.2.5 EUROAPI Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Sex Hormones API Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 TAPI
6.4.1 TAPI Company Information
6.4.2 TAPI Description and Business Overview
6.4.3 TAPI Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 TAPI Sex Hormones API Product Portfolio
6.4.5 TAPI Recent Developments/Updates
6.5 Axplora
6.5.1 Axplora Company Information
6.5.2 Axplora Description and Business Overview
6.5.3 Axplora Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Axplora Sex Hormones API Product Portfolio
6.5.5 Axplora Recent Developments/Updates
6.6 Steroid SpA
6.6.1 Steroid SpA Company Information
6.6.2 Steroid SpA Description and Business Overview
6.6.3 Steroid SpA Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Steroid SpA Sex Hormones API Product Portfolio
6.6.5 Steroid SpA Recent Developments/Updates
6.7 Symbiotec Pharmalab
6.7.1 Symbiotec Pharmalab Company Information
6.7.2 Symbiotec Pharmalab Description and Business Overview
6.7.3 Symbiotec Pharmalab Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Symbiotec Pharmalab Sex Hormones API Product Portfolio
6.7.5 Symbiotec Pharmalab Recent Developments/Updates
6.8 Valdepharm (Fareva)
6.8.1 Valdepharm (Fareva) Company Information
6.8.2 Valdepharm (Fareva) Description and Business Overview
6.8.3 Valdepharm (Fareva) Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Valdepharm (Fareva) Sex Hormones API Product Portfolio
6.8.5 Valdepharm (Fareva) Recent Developments/Updates
6.9 Gonane Pharma
6.9.1 Gonane Pharma Company Information
6.9.2 Gonane Pharma Description and Business Overview
6.9.3 Gonane Pharma Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Gonane Pharma Sex Hormones API Product Portfolio
6.9.5 Gonane Pharma Recent Developments/Updates
6.10 Aspen API
6.10.1 Aspen API Company Information
6.10.2 Aspen API Description and Business Overview
6.10.3 Aspen API Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aspen API Sex Hormones API Product Portfolio
6.10.5 Aspen API Recent Developments/Updates
6.11 Gedeon Richter
6.11.1 Gedeon Richter Company Information
6.11.2 Gedeon Richter Description and Business Overview
6.11.3 Gedeon Richter Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Gedeon Richter Sex Hormones API Product Portfolio
6.11.5 Gedeon Richter Recent Developments/Updates
6.12 Zhejiang Xianju Pharmaceutical
6.12.1 Zhejiang Xianju Pharmaceutical Company Information
6.12.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Xianju Pharmaceutical Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Xianju Pharmaceutical Sex Hormones API Product Portfolio
6.12.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.13 Humanwell Healthcare
6.13.1 Humanwell Healthcare Company Information
6.13.2 Humanwell Healthcare Description and Business Overview
6.13.3 Humanwell Healthcare Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Humanwell Healthcare Sex Hormones API Product Portfolio
6.13.5 Humanwell Healthcare Recent Developments/Updates
6.14 Hunan Norchem Pharmaceutical
6.14.1 Hunan Norchem Pharmaceutical Company Information
6.14.2 Hunan Norchem Pharmaceutical Description and Business Overview
6.14.3 Hunan Norchem Pharmaceutical Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hunan Norchem Pharmaceutical Sex Hormones API Product Portfolio
6.14.5 Hunan Norchem Pharmaceutical Recent Developments/Updates
6.15 Zhejiang Xianju Xianle Pharmaceutical
6.15.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
6.15.2 Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
6.15.3 Zhejiang Xianju Xianle Pharmaceutical Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Zhejiang Xianju Xianle Pharmaceutical Sex Hormones API Product Portfolio
6.15.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
6.16 Hunan Yuxin Pharmaceutical
6.16.1 Hunan Yuxin Pharmaceutical Company Information
6.16.2 Hunan Yuxin Pharmaceutical Description and Business Overview
6.16.3 Hunan Yuxin Pharmaceutical Sex Hormones API Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Hunan Yuxin Pharmaceutical Sex Hormones API Product Portfolio
6.16.5 Hunan Yuxin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sex Hormones API Industry Chain Analysis
7.2 Sex Hormones API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sex Hormones API Production Mode & Process Analysis
7.4 Sex Hormones API Sales and Marketing
7.4.1 Sex Hormones API Sales Channels
7.4.2 Sex Hormones API Distributors
7.5 Sex Hormones API Customer Analysis
8 Sex Hormones API Market Dynamics
8.1 Sex Hormones API Industry Trends
8.2 Sex Hormones API Market Drivers
8.3 Sex Hormones API Market Challenges
8.4 Sex Hormones API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sex Hormones API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sex Hormones API Market Value by Hormone Type, (US$ Million) & (2024 VS 2031)
 Table 3. Global Sex Hormones API Market Value by Source, (US$ Million) & (2024 VS 2031)
 Table 4. Global Sex Hormones API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 5. Global Sex Hormones API Market Competitive Situation by Manufacturers in 2024
 Table 6. Global Sex Hormones API Sales (Tons) of Key Manufacturers (2020-2025)
 Table 7. Global Sex Hormones API Sales Market Share by Manufacturers (2020-2025)
 Table 8. Global Sex Hormones API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 9. Global Sex Hormones API Revenue Share by Manufacturers (2020-2025)
 Table 10. Global Market Sex Hormones API Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 11. Global Key Players of Sex Hormones API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 12. Global Key Manufacturers of Sex Hormones API, Manufacturing Sites & Headquarters
 Table 13. Global Key Manufacturers of Sex Hormones API, Product Type & Application
 Table 14. Global Key Manufacturers of Sex Hormones API, Date of Enter into This Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Sex Hormones API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormones API as of 2024)
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Sex Hormones API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 19. Global Sex Hormones API Sales by Region (2020-2025) & (Tons)
 Table 20. Global Sex Hormones API Sales Market Share by Region (2020-2025)
 Table 21. Global Sex Hormones API Sales by Region (2026-2031) & (Tons)
 Table 22. Global Sex Hormones API Sales Market Share by Region (2026-2031)
 Table 23. Global Sex Hormones API Revenue by Region (2020-2025) & (US$ Million)
 Table 24. Global Sex Hormones API Revenue Market Share by Region (2020-2025)
 Table 25. Global Sex Hormones API Revenue by Region (2026-2031) & (US$ Million)
 Table 26. Global Sex Hormones API Revenue Market Share by Region (2026-2031)
 Table 27. North America Sex Hormones API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. North America Sex Hormones API Sales by Country (2020-2025) & (Tons)
 Table 29. North America Sex Hormones API Sales by Country (2026-2031) & (Tons)
 Table 30. North America Sex Hormones API Revenue by Country (2020-2025) & (US$ Million)
 Table 31. North America Sex Hormones API Revenue by Country (2026-2031) & (US$ Million)
 Table 32. Europe Sex Hormones API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 33. Europe Sex Hormones API Sales by Country (2020-2025) & (Tons)
 Table 34. Europe Sex Hormones API Sales by Country (2026-2031) & (Tons)
 Table 35. Europe Sex Hormones API Revenue by Country (2020-2025) & (US$ Million)
 Table 36. Europe Sex Hormones API Revenue by Country (2026-2031) & (US$ Million)
 Table 37. Asia Pacific Sex Hormones API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 38. Asia Pacific Sex Hormones API Sales by Region (2020-2025) & (Tons)
 Table 39. Asia Pacific Sex Hormones API Sales by Region (2026-2031) & (Tons)
 Table 40. Asia Pacific Sex Hormones API Revenue by Region (2020-2025) & (US$ Million)
 Table 41. Asia Pacific Sex Hormones API Revenue by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Sex Hormones API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Latin America Sex Hormones API Sales by Country (2020-2025) & (Tons)
 Table 44. Latin America Sex Hormones API Sales by Country (2026-2031) & (Tons)
 Table 45. Latin America Sex Hormones API Revenue by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Sex Hormones API Revenue by Country (2026-2031) & (US$ Million)
 Table 47. Middle East and Africa Sex Hormones API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 48. Middle East and Africa Sex Hormones API Sales by Country (2020-2025) & (Tons)
 Table 49. Middle East and Africa Sex Hormones API Sales by Country (2026-2031) & (Tons)
 Table 50. Middle East and Africa Sex Hormones API Revenue by Country (2020-2025) & (US$ Million)
 Table 51. Middle East and Africa Sex Hormones API Revenue by Country (2026-2031) & (US$ Million)
 Table 52. Global Sex Hormones API Sales (Tons) by Type (2020-2025)
 Table 53. Global Sex Hormones API Sales (Tons) by Type (2026-2031)
 Table 54. Global Sex Hormones API Sales Market Share by Type (2020-2025)
 Table 55. Global Sex Hormones API Sales Market Share by Type (2026-2031)
 Table 56. Global Sex Hormones API Revenue (US$ Million) by Type (2020-2025)
 Table 57. Global Sex Hormones API Revenue (US$ Million) by Type (2026-2031)
 Table 58. Global Sex Hormones API Revenue Market Share by Type (2020-2025)
 Table 59. Global Sex Hormones API Revenue Market Share by Type (2026-2031)
 Table 60. Global Sex Hormones API Price (US$/Kg) by Type (2020-2025)
 Table 61. Global Sex Hormones API Price (US$/Kg) by Type (2026-2031)
 Table 62. Global Sex Hormones API Sales (Tons) by Application (2020-2025)
 Table 63. Global Sex Hormones API Sales (Tons) by Application (2026-2031)
 Table 64. Global Sex Hormones API Sales Market Share by Application (2020-2025)
 Table 65. Global Sex Hormones API Sales Market Share by Application (2026-2031)
 Table 66. Global Sex Hormones API Revenue (US$ Million) by Application (2020-2025)
 Table 67. Global Sex Hormones API Revenue (US$ Million) by Application (2026-2031)
 Table 68. Global Sex Hormones API Revenue Market Share by Application (2020-2025)
 Table 69. Global Sex Hormones API Revenue Market Share by Application (2026-2031)
 Table 70. Global Sex Hormones API Price (US$/Kg) by Application (2020-2025)
 Table 71. Global Sex Hormones API Price (US$/Kg) by Application (2026-2031)
 Table 72. Pfizer CentreOne Company Information
 Table 73. Pfizer CentreOne Description and Business Overview
 Table 74. Pfizer CentreOne Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 75. Pfizer CentreOne Sex Hormones API Product
 Table 76. Pfizer CentreOne Recent Developments/Updates
 Table 77. EUROAPI Company Information
 Table 78. EUROAPI Description and Business Overview
 Table 79. EUROAPI Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 80. EUROAPI Sex Hormones API Product
 Table 81. EUROAPI Recent Developments/Updates
 Table 82. GlaxoSmithKline Company Information
 Table 83. GlaxoSmithKline Description and Business Overview
 Table 84. GlaxoSmithKline Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 85. GlaxoSmithKline Sex Hormones API Product
 Table 86. GlaxoSmithKline Recent Developments/Updates
 Table 87. TAPI Company Information
 Table 88. TAPI Description and Business Overview
 Table 89. TAPI Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 90. TAPI Sex Hormones API Product
 Table 91. TAPI Recent Developments/Updates
 Table 92. Axplora Company Information
 Table 93. Axplora Description and Business Overview
 Table 94. Axplora Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 95. Axplora Sex Hormones API Product
 Table 96. Axplora Recent Developments/Updates
 Table 97. Steroid SpA Company Information
 Table 98. Steroid SpA Description and Business Overview
 Table 99. Steroid SpA Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 100. Steroid SpA Sex Hormones API Product
 Table 101. Steroid SpA Recent Developments/Updates
 Table 102. Symbiotec Pharmalab Company Information
 Table 103. Symbiotec Pharmalab Description and Business Overview
 Table 104. Symbiotec Pharmalab Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 105. Symbiotec Pharmalab Sex Hormones API Product
 Table 106. Symbiotec Pharmalab Recent Developments/Updates
 Table 107. Valdepharm (Fareva) Company Information
 Table 108. Valdepharm (Fareva) Description and Business Overview
 Table 109. Valdepharm (Fareva) Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 110. Valdepharm (Fareva) Sex Hormones API Product
 Table 111. Valdepharm (Fareva) Recent Developments/Updates
 Table 112. Gonane Pharma Company Information
 Table 113. Gonane Pharma Description and Business Overview
 Table 114. Gonane Pharma Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 115. Gonane Pharma Sex Hormones API Product
 Table 116. Gonane Pharma Recent Developments/Updates
 Table 117. Aspen API Company Information
 Table 118. Aspen API Description and Business Overview
 Table 119. Aspen API Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 120. Aspen API Sex Hormones API Product
 Table 121. Aspen API Recent Developments/Updates
 Table 122. Gedeon Richter Company Information
 Table 123. Gedeon Richter Description and Business Overview
 Table 124. Gedeon Richter Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 125. Gedeon Richter Sex Hormones API Product
 Table 126. Gedeon Richter Recent Developments/Updates
 Table 127. Zhejiang Xianju Pharmaceutical Company Information
 Table 128. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 129. Zhejiang Xianju Pharmaceutical Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 130. Zhejiang Xianju Pharmaceutical Sex Hormones API Product
 Table 131. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 132. Humanwell Healthcare Company Information
 Table 133. Humanwell Healthcare Description and Business Overview
 Table 134. Humanwell Healthcare Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 135. Humanwell Healthcare Sex Hormones API Product
 Table 136. Humanwell Healthcare Recent Developments/Updates
 Table 137. Hunan Norchem Pharmaceutical Company Information
 Table 138. Hunan Norchem Pharmaceutical Description and Business Overview
 Table 139. Hunan Norchem Pharmaceutical Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 140. Hunan Norchem Pharmaceutical Sex Hormones API Product
 Table 141. Hunan Norchem Pharmaceutical Recent Developments/Updates
 Table 142. Zhejiang Xianju Xianle Pharmaceutical Company Information
 Table 143. Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
 Table 144. Zhejiang Xianju Xianle Pharmaceutical Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 145. Zhejiang Xianju Xianle Pharmaceutical Sex Hormones API Product
 Table 146. Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
 Table 147. Hunan Yuxin Pharmaceutical Company Information
 Table 148. Hunan Yuxin Pharmaceutical Description and Business Overview
 Table 149. Hunan Yuxin Pharmaceutical Sex Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 150. Hunan Yuxin Pharmaceutical Sex Hormones API Product
 Table 151. Hunan Yuxin Pharmaceutical Recent Developments/Updates
 Table 152. Key Raw Materials Lists
 Table 153. Raw Materials Key Suppliers Lists
 Table 154. Sex Hormones API Distributors List
 Table 155. Sex Hormones API Customers List
 Table 156. Sex Hormones API Market Trends
 Table 157. Sex Hormones API Market Drivers
 Table 158. Sex Hormones API Market Challenges
 Table 159. Sex Hormones API Market Restraints
 Table 160. Research Programs/Design for This Report
 Table 161. Key Data Information from Secondary Sources
 Table 162. Key Data Information from Primary Sources
 Table 163. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sex Hormones API
 Figure 2. Global Sex Hormones API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sex Hormones API Market Share by Type: 2024 & 2031
 Figure 4. Estrogens Product Picture
 Figure 5. Progestins Product Picture
 Figure 6. Androgens Product Picture
 Figure 7. Global Sex Hormones API Market Value by Hormone Type, (US$ Million) & (2020-2031)
 Figure 8. Global Sex Hormones API Market Share by Hormone Type: 2024 VS 2031
 Figure 9. Progesterone Product Picture
 Figure 10. Estradiol Product Picture
 Figure 11. Ethinylestradiol Product Picture
 Figure 12. Levonorgestrel Product Picture
 Figure 13. Megestrol Product Picture
 Figure 14. Testosterone Product Picture
 Figure 15. Other Product Picture
 Figure 16. Global Sex Hormones API Market Value by Source, (US$ Million) & (2020-2031)
 Figure 17. Global Sex Hormones API Market Share by Source: 2024 VS 2031
 Figure 18. Natural Hormones Product Picture
 Figure 19. Synthetic Hormones Product Picture
 Figure 20. Global Sex Hormones API Market Value by Application (2020-2031) & (US$ Million)
 Figure 21. Global Sex Hormones API Market Share by Application: 2024 & 2031
 Figure 22. Oral Preparations
 Figure 23. Topical Preparations
 Figure 24. Injections
 Figure 25. Global Sex Hormones API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 26. Global Sex Hormones API Market Size (2020-2031) & (US$ Million)
 Figure 27. Global Sex Hormones API Sales (2020-2031) & (Tons)
 Figure 28. Global Sex Hormones API Average Price (US$/Kg) & (2020-2031)
 Figure 29. Sex Hormones API Report Years Considered
 Figure 30. Sex Hormones API Sales Share by Manufacturers in 2024
 Figure 31. Global Sex Hormones API Revenue Share by Manufacturers in 2024
 Figure 32. Global 5 and 10 Largest Sex Hormones API Players: Market Share by Revenue in Sex Hormones API in 2024
 Figure 33. Sex Hormones API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 34. Global Sex Hormones API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 35. North America Sex Hormones API Sales Market Share by Country (2020-2031)
 Figure 36. North America Sex Hormones API Revenue Market Share by Country (2020-2031)
 Figure 37. United States Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Canada Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Europe Sex Hormones API Sales Market Share by Country (2020-2031)
 Figure 40. Europe Sex Hormones API Revenue Market Share by Country (2020-2031)
 Figure 41. Germany Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. France Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. U.K. Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Italy Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Russia Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Asia Pacific Sex Hormones API Sales Market Share by Region (2020-2031)
 Figure 47. Asia Pacific Sex Hormones API Revenue Market Share by Region (2020-2031)
 Figure 48. China Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Japan Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. South Korea Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. India Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Australia Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. China Taiwan Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Latin America Sex Hormones API Sales Market Share by Country (2020-2031)
 Figure 56. Latin America Sex Hormones API Revenue Market Share by Country (2020-2031)
 Figure 57. Mexico Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Brazil Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Argentina Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Colombia Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Middle East and Africa Sex Hormones API Sales Market Share by Country (2020-2031)
 Figure 62. Middle East and Africa Sex Hormones API Revenue Market Share by Country (2020-2031)
 Figure 63. Turkey Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 64. Saudi Arabia Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 65. UAE Sex Hormones API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 66. Global Sales Market Share of Sex Hormones API by Type (2020-2031)
 Figure 67. Global Revenue Market Share of Sex Hormones API by Type (2020-2031)
 Figure 68. Global Sex Hormones API Price (US$/Kg) by Type (2020-2031)
 Figure 69. Global Sales Market Share of Sex Hormones API by Application (2020-2031)
 Figure 70. Global Revenue Market Share of Sex Hormones API by Application (2020-2031)
 Figure 71. Global Sex Hormones API Price (US$/Kg) by Application (2020-2031)
 Figure 72. Sex Hormones API Value Chain
 Figure 73. Channels of Distribution (Direct Vs Distribution)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture